Catalog Advanced Search

Search by Categories
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Cardiac Risk in Liver Transplantation: Getting to the “Heart” of the Matter

    Contains 1 Component(s) Recorded On: 09/10/2018

    Webinar hosted by the Cardiopulmonary Affinity group September 10, 2018.

    The overall objective of this activity is to address the epidemiology, risk factors and key challenges in the evaluation and management of cardiovascular disease in liver transplant candidates. In particular, we will discuss the evolving role of cirrhotic cardiomyopathy as a marker of ongoing cardiac injury.  

    Lisa VanWagner (Moderator)

    Dr. Lisa VanWagner is an Assistant Professor of Medicine and Preventive Medicine in the Division Gastroenterology & Hepatology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.  She is board certified in Transplant Hepatology.  Her laboratory utilizes human population-based approaches, large electronic health record data analysis and health services research methods to define and characterize cardiovascular disease risk prediction, prevention and treatment approaches in patients with chronic liver disease.  Her research group developed the first simple scoring model (CAR-OLT score) — accessible via web or smartphone apps — which enables healthcare providers, caregivers and patients to estimate 1-year risk for cardiovascular complications after liver transplantation.

    Sam Lee (Moderator)

    Mario Altieri

    Dr. Mario Altieri is currently the medical director of the liver transplant program at the University Hospital Center in Caen, France since November, 2012. He did his Fellowship in intensive care medicine and Fellowship in multiple organ transplantation (liver, kidney and pancreas) at Strasbourg University France Hospital, University Center Hospital  HUC. He was the Chief of residency in Internal Medicine Cordoba, Argentina (Specialist certified NUCA) and was professor in intensive care medicine catholic University of Cordoba from 2000 to 2002.

    Manhal Izzy

    Dr. Manhal Izzy is a transplant hepatologist and an assistant professor at Vanderbilt University School of Medicine. He is a member of the educational committee of the International Liver Transplantation Society (ILTS). His research focuses on cardiovascular outcomes in patients with liver disease.

  • Implications of the Hepatitis C Epidemic on Women & Children

    Contains 1 Component(s) Recorded On: 09/07/2018

    Webinar hosted by the Hepatitis C Special interest group September 7, 2018.

    Chronic hepatitis C infection remains a major public health burden with substantial morbidity and mortality. In this program, expert hepatologists will provide a state-of-the-art update on the evolving epidemiology, natural history, and evidence-based management of hepatitis C infection in women of child-bearing age, pregnancy, and children.

    Dawn S. Harrison (Moderator)

    Dawn S. Harrison is a Family Nurse Practitioner specializing in Gastroenterology and Hepatology at The University of North Carolina Medical Center, Chapel Hill, North Carolina. She completed her Bachelor's of Science degree in Nursing from Radford University in Radford, Virginia and then earned her Master's of Science in Nursing as a Family Nurse Practitioner at Graceland University in Independence, Missouri.  Her Doctoral of Nursing Practice degree was acquired from The University of Alabama in Tusculoosa, Alabama. She holds a national certification with the American Nurses Credentialing Center (ANCC) as Family Nurse Practitioner. 

    Joseph K. Lim (Moderator)

    Joseph K. Lim, MD, FAASLD is a Professor of Medicine in the Section of Digestive Diseases and Yale Liver Center at Yale University School of Medicine in New Haven, CT where he serves as Director of the Viral Hepatitis Program.  He runs an active outcomes research and clinical trials program addressing viral hepatitis and fatty liver disease.  He is a member of the steering committee for the AASLD HCV SIG.

     

    Nancy S. Reau

    Dr. Nancy Reau is currently Associate Director of Solid Organ Transplantation and Section Chief of Hepatology at Rush University Medical Center. Dr Reau’s research interest is in viral hepatitis drug development as well as utilisation. She has authored or co-authored over 100 peer-reviewed articles, invited reviews, editorials and online programmes, as well as several book chapters, and two books. She is the editor in chief for Clinical Liver Disease, the AASLD multimedia journal.  She was one of the original authors of the AASLD/IDSA hepatitis C guidance document.  She is currently a member of the steering committee for the hepatitis C special interest group for the AASLD and is a member of the gastroenterology writing committee for the American Board of Internal Medicine.

     

    Tatyana Kushner

    Tatyana Kushner, MD, MSCE, is Assistant Professor in the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai in New York. She completed her medical school and internal medicine training at Mount Sinai School of Medicine, a fellowship in gastroenterology and a masters in clinical epidemiology at the University of Pennsylvania, and a fellowship in transplant hepatology at the University of California, San Francisco (UCSF). Her research focuses on both epidemiologic and patient-centered outcomes in viral hepatitis, with an emerging focus in the area of women’s health and pregnancy care, and the goal of developing and studying interventions to improve clinical outcomes in this patient population. She has recently established a Women's Liver Clinic at Mount Sinai in order to enhance the diagnosis and management of liver disease during pregnancy and post-delivery, particularly of hepatitis B and hepatitis C. 

     

    Karen Murray

    Dr. Karen Murray is board certified in pediatric gastroenterology and pediatric transplant hepatology. In addition to providing clinical care in gastroenterology, hepatology and transplantation, she has an active clinical research program. Her main focus is childhood liver disease, especially the treatment of hepatitis B and C viral infections, non-alcoholic fatty liver disease and cholestatic liver diseases in childhood. Murray is a professor of pediatrics at University of Washington School of Medicine and past president of Seattle Children’s medical staff. She is on the steering committees of three National Institute of Diabetes and Digestive and Kidney Diseases clinical research networks related to her research.

  • Unraveling the New UNOS Liver Allocation Policy

    Contains 1 Component(s) Recorded On: 09/04/2018

    Webinar hosted by the Liver Transplantation and Surgery Special Interest Group and Liver Transplantation Journal September 4, 2018.

    The new UNOS organ allocation policy is scheduled to go into effect in December 2018. Work your way through the changes and challenges with the Chair of the AASLD Liver Transplantation SIG and Editor-in-Chief of Liver Transplantation in this first of a series of webinars brought to you by a collaboration of the SIG and journal. 

    Paul Martin (Moderator)

    Paul Martin MD, FAASLD is Professor of Medicine and Chief of the Divisions of Gastroenterology and Hepatology at the University of Miami, USA. He is a native of Dublin, Ireland, where he graduated from medical school at University College, Dublin. He specialized in internal medicine and gastroenterology, training initially in Dublin and subsequently in Canada. He trained in hepatology as a Medical Staff Fellow in the Liver Unit, NIH, Maryland, USA. He is Editor-in Chief of Liver Transplantation and Editor of Handbook of Liver Disease. He was previously a Councilor for AST of the American Society of Transplant. He has had a long standing interest in viral hepatitis and organ transplant. 

    Timucin Taner

    Dr. Taner is a transplant surgeon, and surgical director of liver transplantation at Mayo Clinic, Rochester. He is a member of the AASLD Surgery and Liver Transplantation Committee, and currently serves as the chair of the Liver Transplantation SIG Education Subcommittee.

    James Trotter

    Dr. James Trotter is currently the medical director of liver transplantation at Baylor University Medical Center. He is also the principal investigator of the Living donor liver transplant Cohort Study at the National Institutes of Health. Dr. Trotter is the associate editor of the Liver Transplantation journal.

  • Portal Hypertension SIG: Critical Review of Invasive Interventions in Patients with Portal Hypertension

    Contains 9 Component(s) Recorded On: 10/20/2017

    AASLD's Special Interest Group (SIG) Sessions presented at The Liver Meeting® 2017.

    Join international portal hypertension experts for a critical review of several invasive interventions performed in patients with the disease. This session will look at potential situations that may interfere with the accuracy and reproducibility of hepatic venous pressure gradient and portal pressure gradient measurements in the course of TIPS. It will also discuss recommendations for standardizing the procedure. Attendees will hear a review of invasive procedures used to diagnose and treat cardiofundal and ectopic varices as well as new therapeutic strategies to solve portal hypertension in patients — both children and adults — with portal cavernoma. Finally, the session will review the potential role of splenectomy or spleen embolization in the treatment of hypersplenism and of the closing or reduction of TIPS or large portocollateral shunts in patients with severe refractory hepatic encephalopathy.

    Juan C. Garcia-Pagan

    Juan Carlos Garcia-Pagán is a Senior consultant in Hepatology and Head of the Hepatic Hemodynamic section at the Hospital Clinic in Barcelona, Spain and Associate Professor at the University of Barcelona.

    He is currently sharing its clinical activity in the hospital with its clinical and basic research at the Institut de Investigacións Biomediques August Pi i Sunyer (IDIBAPS) and is also member of the Centro para Investigación Biomédica en Red de enfermedades hepaticas y digestivas (CIBEREHD).  The main research of Interest are: Pathophysiology and treatment of portal hypertension in cirrhosis and of vascular disorders of the liver. He is currently the chair of the EASL-VALDIG (Vascular liver disease group) .

    Zachary Henry

    Puneeta Tandon

    Dr. Tandon is an Associate Professor of Medicine, Director of the Cirrhosis Care Clinic and Transplant Hepatologist at the University of Alberta in Edmonton, Alberta, Canada. She completed her Gastroenterology and Hepatology training at the University of Alberta with fellowships at Yale University and the Hospital Clinic in Barcelona. Her clinical practice and research are focused on cirrhosis. Research interests include acute on chronic liver failure and its related complications, sarcopenia, frailty, nutrition, exercise therapy and the early integration of palliative care principles in cirrhosis.

    Frederik Nevens

    Riccardo A. Superina

    Riad Salem

    Wael E. Saad

    Dr. Saad is a Physician of 20 years and is internationally recognized for liver disease including liver transplantation, hepatobiliary disease and portal hypertension. He has over 240 publications and over 70 book chapters and is an author of 4 books. He completed his residency at the University of Rochester, New York and his Fellowship in Vascular & Interventional Radiology at Mallinckrodt Institute of radiology, Washington University, St. Louis. He practiced Interventional Radiology at the University of Rochester and University of Virginia, where he was the program director of the Vascular & Interventional Radiology Fellowship, before coming to the University of Michigan in 2013. Dr. Saad is active in the Society of Interventional Radiology (SIR) and was awarded the SIR-Fellowship in 2010. He served as the Chairman of the SIR Standards of Practice Committee from 2011 through to 2014.

  • Basic Research Workshop

    Product not yet rated Contains 9 Component(s) Recorded On: 11/13/2016

    AASLD's Basic Research Workshop presented at The Liver Meeting® 2016.

    This workshop will focus on how inducible pluripotent stem cells (iPSCs) can be used to produce liver cells and organoids. These are exciting new tools for experimental hepatology and hold great promise for clinical hepatology. The generation of iPSC-derived liver cells enables studies of the pathophysiology of several human conditions and to explore the effects of new drugs and treatment following a personalized medicine approach. iPSCs can also give rise to multicellular liver organoids with the potential to recapitulate the cellular ecosystem of a human liver, maintain the inter-cellular relationships, and reproduce models of liver disease as experimental models and potential organ-replacement strategies.

    Mario Strazzabosco

    Jorge A. Bezerra

    Stephen A. Duncan

    Takanori Takebe

    Holger Willenbring

    Romina Fiorotto

    Andrew A. Wilson

  • Clinical Hepatology Update 2017

    Contains 26 Component(s) Recorded On: 06/03/2017

    This course offers didactic lectures in 6 topic areas relevant to mid-level hepatology professionals.

    The 2017 Clinical Hepatology Course is a prime opportunity for hepatology professionals to stay updated on the state-of-the-art management of liver disease. Presentations will offer clinically relevant insights on many aspects in patient care in liver disease, and a chance to discuss controversies commonly seen in clinical practice with key leaders in the field.

    This 1 1/2 day course will offer didactic lectures in 6 topic areas relevant to mid-level hepatology professionals. A breakout session titled Preventative Health Strategies in the Outpatient Management of Cirrhosis will feature a small, interactive discussion with session organizers and networking opportunities with other attendees.

    K. Rajender Reddy

    Jayant A. Talwalker

    Frank Lammert

    Christopher L. Bowlus

    Dr. Christopher Bowlus obtained his medical degree at St. Louis University and completed his postgraduate training at University of California Davis and Yale University. Dr. Bowlus is Professor of Medicine and Chief of the Division of Gastroenterology and Hepatology at UC Davis. Dr. Bowlus conducts clinical and translational research in autoimmune liver diseases including primary biliary cholangitis and primary sclerosing cholangitis.

    Bernd Schnabl

    Jennifer C. Lai

    Dr. Lai is a transplant hepatologist, on faculty at the University of California, San Francisco.  Her long-term mission is to help patients with end-stage liver disease survive to and thrive after liver transplantation.  Her primary research focuses on integrating core geriatric principles, such as frailty and physical function, into the day-to-day practice of hepatology and transplant medicine to improve the care of her patients.  She is the founder and principal investigator of the Functional Assessment in Liver Transplantation (FrAILT) Study, a multi-center collaboration aimed at investigating the impact of frailty on liver transplant outcomes.  For her work, she has been named a Beeson Scholar in Aging Research by the National Institute on Aging and a Top 40 Under 40 Leader by the San Francisco Business Times.

    Michael B. Fallon

    Juan G. Abraldes

    Ram M. Subramanian

    Michael R. Lucey

    Kathleen E. Corey

    Natalie J. Torok

    R. Todd Stravitz

    Michael L. Schilsky

    Patrick S. Kamath

    Hashem B. El-Serag

    Saul J. Karpen

    Tram T. Tran

    Dr. Tran is Medical Director of Liver Transplantation at Cedars-Sinai Medical Center and Professor of Medicine at Geffen UCLA School of Medicine. Dr. Tran has broad research interests in the areas of viral hepatitis B and C, liver disease in pregnancy and liver transplantation. She is an internationally recognized expert and NIH-funded researcher in the field of chronic hepatitis B, and is active in patient and community advocacy on hepatitis B prevention and treatment. She has authored and co-authored numerous abstracts, papers and chapters in these fields and published in journals.

    Timothy J. Davern

  • Clinical Practice SIG: Managing and Growing a Hepatology Clinical Practice

    Product not yet rated Contains 10 Component(s) Recorded On: 11/11/2016

    AASLD's Clinical Practice SIG presented at The Liver Meeting® 2016.

    As the practice of hepatology has matured over the past decade many AASLD members have successfully developed or transitioned to community-based hepatology practices in one of three major areas: a community based health care system, a multi-speciality group practice or a hepatology-only medical practice. This workshop will bring together hepatologists, practice administrators, lawyers with medical practice speciality who work in these environments to share the medical, financial and legal models they utilize to develop successful, rewarding and financially feasible community-based hepatology practices.

    Marcelo Kugelmas

    David E. Bernstein

    Stephen A. Harrison

    Victor R. Araya

    Mitchell L. Shiffman

    Mitchell A. Mah'moud

    Tarek I. Hassanein

  • Career Development Workshop

    Product not yet rated Contains 7 Component(s) Recorded On: 11/11/2016

    AASLD's Career Development Workshop presented at The Liver Meeting® 2016.

    The main objective of this program is to educate medical students or residents who are considering a career in hepatology about training opportunities as well as arm the current GI and/or hepatology fellows with knowledge to help them succeed in academic hepatology. Time will be decidated specifically to discussion of clinical and basic science research, funding mechanisms, mentorship and important career crossroads. An overview of the responsibilities and opportunities of an academic hepatologist and clinician educator will all be provided. Community based, hybrid practices, and VA based hepatology opportunities/practice models will be discussed. Lastly, through panel discussion, the common questions regarding interview and contract negotiations will be reviewed by members of the panel. 

    Michael D. Leise

    Dr. Leise finished his internal medicine residency, chief residency, Gastroenterology and Transplant Hepatology fellowships at Mayo Clinic, Rochester.  He is an Assistant Professor of Medicine with research interests in Hepatitis C, hepatic encephalopathy, and liver transplant outcomes.

    Oren K. Fix

    Oren K. Fix, MD, MSc, FAASLD is Medical Director of the Liver Transplant Program at Swedish Medical Center in Seattle. He earned his medical degree at SUNY Buffalo School of Medicine and a masters degree in Epidemiology from Boston University School of Public Health. He completed his Internal Medicine residency and Gastroenterology fellowship at Boston University and Transplant Hepatology fellowship at University of California San Francisco (UCSF). Dr. Fix was a site principal investigator in the NIH-funded Acute Liver Failure Study Group for 8 years at University of Washington and UCSF. He has published over 45 peer-reviewed manuscripts and book chapters, many on the topic of acute liver failure.

    William Sanchez

    Harmeet Malhi

    Archita P. Desai

    Mark W. Russo

  • 2017 Postgraduate Course: 21st Century Hepatology: Translating Discoveries into Practice

    Contains 21 Component(s) Recorded On: 10/21/2017

    AASLD's Postgraduate Course: 21st Century Hepatology presented at The Liver Meeting® 2017.

    Now, more than ever, hepatologists and hepatology health professionals must guide personalized treatment plans for their patients. 21st Century Hepatology will help you do just that by discussing new and best evidence, therapeutic advances, and breakthroughs on the horizon. From the application of biomarkers to genetics and lifestyle, this course offers a state-of-the art look at translating discoveries into modern-day hepatology practice.

    Ronald J. Sokol

    Michael P. Manns

    Marc G. Ghany

    Dr. Ghany is an Investigator at the Liver Diseases Branch of the National Institute of Diabetes and Digestive and Kidney Diseases, and at Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda. He is member the Physician Consortium for Practice Improvement for Hepatitis C, which is jointly sponsored by the American Medical Association and AASLD and serves on the hepatitis C Guidance panel which is jointly sponsored by the AASLD and Infectious Diseases Society of America. His work has been honored with the Regal Award for Excellence in Gastrointestinal and Liver Disease and with several NIDDK service awards including the Director’s Award. He received his M.B. and B.Ch. from the Royal College of Surgeon’s, Dublin, and Master of Health Sciences in Clinical Research, Duke University. He completed residency at the Hospital of Saint Raphael, New Haven, Connecticut, a fellowship in gastroenterology at Tulane University, New Orleans, and a clinical fellowship at the Liver Diseases Section, NIDDK. Dr. Ghany’s focus is on translational research to improve the care and treatment outcomes of patients with chronic viral hepatitis. 

     

    David R. Nelson

    Jasmohan S. Bajaj

    David E. Kleiner

    Rohit Loomba

    Dr. Rohit Loomba is a Professor of Medicine (with tenure), Director of Hepatology, and Vice Chief, Division of Gastroenterology at University of California at San Diego. He is an internationally recognized thought leader in translational research and innovative clinical trial design in nonalcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH), and non-invasive assessment of steatosis and fibrosis using advanced imaging modalities. Dr. Loomba is the founding director of the UCSD NAFLD Research Center where his team is conducting cutting edge research in all aspects of NAFLD including non-invasive biomarkers, genetics, epidemiology, clinical trial design, imaging end-points, and integrated OMICs using microbiome, metabolome and lipidome.

    Quentin M. Anstee

    Gyongyi Szabo

    Hashem B. El-Serag

    Jorge A. Marrero

    Laura M. Kulik

    Francis Yao

    Cynthia Levy

    Cynthia Levy, MD, FAASLD is currently a Professor of Medicine in the Division of Hepatology at the University of Miami Miller School of Medicine. Dr. Levy received her MD from Universidade Federal do Rio de Janeiro, Brazil. She completed an Internal Medicine residency at University of Miami, a Gastroenterology Fellowship at Mayo Clinic, Rochester, and a Transplant Hepatology Fellowship at University of Florida, Gainesville, having received an AASLD Fellowship Award. Dr. Levy is a member of the AASLD Practice Guidelines Committee and of the ABIM Test and Policy Committee on Transplant Hepatology.  At the University of Miami, Dr. Levy is the program director for the Transplant Hepatology Fellowship program and Associate Director for the Schiff Center for Liver Diseases, where she conducts several industry-sponsored and investigator-initiated studies for cholestatic and autoimmune liver diseases.

    Jorge A. Bezerra

    Guruprasad P. Aithal

    Jennifer C. Lai

    Dr. Lai is a transplant hepatologist, on faculty at the University of California, San Francisco.  Her long-term mission is to help patients with end-stage liver disease survive to and thrive after liver transplantation.  Her primary research focuses on integrating core geriatric principles, such as frailty and physical function, into the day-to-day practice of hepatology and transplant medicine to improve the care of her patients.  She is the founder and principal investigator of the Functional Assessment in Liver Transplantation (FrAILT) Study, a multi-center collaboration aimed at investigating the impact of frailty on liver transplant outcomes.  For her work, she has been named a Beeson Scholar in Aging Research by the National Institute on Aging and a Top 40 Under 40 Leader by the San Francisco Business Times.

    Paolo Angeli

    R. Todd Stravitz

    Jacqueline G. O'Leary

    Guadalupe Garcia-Tsao

    Dr. Garcia-Tsao is Professor of Medicine, Chief of Digestive Diseases and Program Director of the Hepatitis C Resource Center at Veteran’s Administration-Connecticut Healthcare System, as well as Director of Clinical and Translational Core at Yale Liver Center. She is a past president of AASLD. She received her M.D. and training at Universidad Nacional Autónoma de Mexico. Her primary research focus is on clinical research which focuses on cirrhosis and its complications, and she also is involved in the study of bacterial infections in cirrhosis, a complication that is often overlooked.

  • Hepatology Associates Course

    Contains 12 Component(s) Recorded On: 10/22/2017

    AASLD's Hepatology Associates Course presented at The Liver Meeting® 2017.

    This comprehensive program has been designed to improve the treatment and management of patients with liver disease. By highlighting current data to support effective and efficient patient-centered care, attendees will have the ability to utilize medical knowledge and research to provide quality evidence-based practice. In addition, the program will address how quality improvement measures can be enhanced by working with interdisciplinary teams, and encourage attendees to evaluate their current practices by assimilating updated scientific evidence into patient focused care and management.

    Cynthia L. Solomon

    Daniel M. Tassone

    Nicolas M. Intagliata

    Rhonda K. Martin

    Maria L. Yataco

    Tram T. Tran

    Dr. Tran is Medical Director of Liver Transplantation at Cedars-Sinai Medical Center and Professor of Medicine at Geffen UCLA School of Medicine. Dr. Tran has broad research interests in the areas of viral hepatitis B and C, liver disease in pregnancy and liver transplantation. She is an internationally recognized expert and NIH-funded researcher in the field of chronic hepatitis B, and is active in patient and community advocacy on hepatitis B prevention and treatment. She has authored and co-authored numerous abstracts, papers and chapters in these fields and published in journals.

    Cristal L. Brown

    Amanda J. Chaney

    Michael Fuchs

    Cheryl Dale